Allspring Global Investments Holdings, LLC
Position in NAGE — Niagen Bioscience, Inc.
CIK 1890906
CHARLOTTE, NC
Position in NAGE
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$83,150
-$24,429 QoQ
Shares Held
18,855
+11.5% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
7 quarters on record
Voting authority
Sole 35%
Shared 0%
None 65%
Common Shares in NAGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Allspring Global Investments Holdings, LLC holds $702,720,315 across 64 Biotechnology names. NAGE ranks #62 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
175,311 | $128,020,857 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
281,793 | $93,236,848 | |
| 3 | EXEL |
Exelixis, Inc.
|
1,707,715 | $73,243,895 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
889,356 | $66,043,575 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
123,760 | $55,263,790 | |
| 6 | INSM |
INSMED Inc
|
282,734 | $46,232,662 | |
| 7 | ASND |
Ascendis Pharma A/S
|
184,224 | $42,137,554 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
52,497 | $40,561,281 |
All Filings in NAGE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $83,150 | 18,855 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $107,579 | 16,915 | Shares | Defined | 2026-01-15 | |
| 2025-09-30 | $144,027 | 15,437 | Shares | Defined | 2025-10-20 | |
| 2025-06-30 | $224,651 | 15,590 | Shares | Defined | 2025-07-25 | |
| 2024-09-30 | $6,372 | 1,746 | Shares | Defined | 2024-10-18 | |
| 2022-03-31 | $195,727 | 79,564 | Shares | Defined | 2022-04-27 | |
| 2021-12-31 | $297,569 | 79,564 | Shares | Defined | 2022-01-28 | |
| No filing history on record for this holder in this stock. | ||||||